The National Institute for Health and Clinical Excellence (NICE)
www.nice.org.uk defines guidelines as:
“Clinical guidelines are recommendations by NICE on the appropriate treatment and care of people with specific diseases and conditions within the NHS. They are based on the best available evidence. While clinical guidelines help health professionals in their work, they do not replace their knowledge and skills.”
NICE guidelines relevant to lymphoma treatment:
- Improving Outcomes in Haemato-Oncology Cancer
- Rituximab for the Treatment of Follicular Lymphoma
- The Clinical Effectiveness and Cost-Effectiveness of Rituximab for Follicular Lymphoma
- Rituximab for Aggressive Non-Hodgkin’s Lymphoma
Further useful links:
British Committee for Standards in Haematology (BCSH)
http://www.bcshguidelines.com
